BP Ousted Chair Albert Manifold Denounces Allegations as Lies Amid Boardroom Turmoil Torrent Pharma Reports 26 Decline in Q4 Profit on Acquisition and Severance Costs Board Approves 5000 Crore QIP UK Ministers Urged to Proceed with ZeroHours Contracts Ban Amid Business Opposition JPMorgan Flags Bitcoin ETF Outflows as Sign of Cooling Speculative Trade Western Digital WDC Emerges as Potential Top Performer Among Data Center Stocks in 2026 BJs Wholesale Revamps Store Strategy as Consumer Spending Softens SWMR Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction BCHT Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Unreported CUZ Q1 2026 Earnings EPS Beats Estimates by 155 Shares Edge Higher NI Holdings Inc NODK Q4 2022 Earnings Modest Profit Amid Limited Disclosure GILD Q1 2026 Earnings EPS Surpasses Estimates Shares Rally 296 VICI Q1 2026 Earnings Strong EPS Surprise of 1443 Despite Flat Stock Reaction National Storage Affiliates Trust NSA Holds Steady Near 43 Amid Modest Gains Target Corporation TGT Holds Near Support With Slight Uptick Bluerock Acquisition Corp Unit BLRKU Holds Steady at 1002 Amid Quiet Trading Abundia Global Impact Group Surges Is AGIG Breaking Out from Consolidation TotalEnergies TTE Edges Higher in Cautious Trading Holds Near Key Support Irans HighSeas Black Market The Network Behind Illicit Oil Flows MXL Q1 2026 Earnings EPS Beats Estimates by Over 22 Yet Shares Decline Garmin Ltd GRMN Holds Steady Near Key Resistance Level ADAMZ Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat Despite Modest Share Decline ADAG Q2 2025 Earnings EPS Miss as ClinicalStage Biotech Focuses on Pipeline Advancement HTZ Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares Purple Innovation PRPL Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid Revenue Disclosures Cadeler AS CDLR Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Inches Higher Customers Bancorp Inc CUBI Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase